Platelet Size Predicts Mortality in Patients with Sepsis
By HospiMedica International staff writers Posted on 26 Jul 2012 |
A new study suggests that the mean platelet volume (MPV) is an easily accessible prognostic marker of mortality in sepsis.
Researchers at Klinikum St. Georg (Leipzig, Germany) conducted a study involving 191 patients (median age 72, 38% women) with documented sepsis. The researchers prospectively evaluated MPV at admission, at the onset of sepsis, at the diagnosis of sepsis, and during the course of the disease, as a marker for the prediction of outcomes. These data were compared with data from 56 patients (median age was 74, 45.5% women) with acute upper and lower gastrointestinal (GI) bleeding, who served as control subjects. Data on other standard laboratory biomarkers and clinical parameters were collected at the same time.
The results showed MPV on admission and at the onset of symptoms was strongly associated with death. Of 183 sepsis patients, 41 (21.5%) that died had a higher MPV than survivors (9.6 vs. 9.19 femtoliter (fL), respectively). At the time of positive blood cultures, those values had increased (11.2 vs. 9.7 fL).
Parameters of temperature, leukocyte count, lactate, procalcitonin, and C-reactive protein (CRP) values, on the other hand, were not at all predictive of outcome. The researchers then determined that the best predictor of death or survival was when they used an MPV discriminatory value of 8.7 fL. The study was presented as poster session at the 15th International Congress on Infectious Diseases, held during June 2012 in Bangkok (Thailand).
“This figure is at the high end of the normal range of platelet volumes, but is still highly predictive of poor outcome, namely death, in patients with sepsis,” said lead author and study presenter Thomas Grünewald, MD, PhD, head of the division of infectious diseases and tropical medicine. “We saw that patients with MPVs higher than 8.7 are much more prone — the odds ratio is 3.2 — to worse outcomes (for example, death) than patients with MPVs lower than 8.7.”
MPV is a machine-calculated measurement of the average size of platelets found in blood and is typically included in blood tests as part of the CBC. Since the average platelet size is larger when the body is producing increased numbers of platelets, the MPV test results can be used to make inferences about platelet production in bone marrow or platelet destruction problems. A typical range of platelet volumes is 9.7–12.8 fL, equivalent to spheres 2.65 to 2.9 µm in diameter.
Related Links:
Klinikum St. Georg
Researchers at Klinikum St. Georg (Leipzig, Germany) conducted a study involving 191 patients (median age 72, 38% women) with documented sepsis. The researchers prospectively evaluated MPV at admission, at the onset of sepsis, at the diagnosis of sepsis, and during the course of the disease, as a marker for the prediction of outcomes. These data were compared with data from 56 patients (median age was 74, 45.5% women) with acute upper and lower gastrointestinal (GI) bleeding, who served as control subjects. Data on other standard laboratory biomarkers and clinical parameters were collected at the same time.
The results showed MPV on admission and at the onset of symptoms was strongly associated with death. Of 183 sepsis patients, 41 (21.5%) that died had a higher MPV than survivors (9.6 vs. 9.19 femtoliter (fL), respectively). At the time of positive blood cultures, those values had increased (11.2 vs. 9.7 fL).
Parameters of temperature, leukocyte count, lactate, procalcitonin, and C-reactive protein (CRP) values, on the other hand, were not at all predictive of outcome. The researchers then determined that the best predictor of death or survival was when they used an MPV discriminatory value of 8.7 fL. The study was presented as poster session at the 15th International Congress on Infectious Diseases, held during June 2012 in Bangkok (Thailand).
“This figure is at the high end of the normal range of platelet volumes, but is still highly predictive of poor outcome, namely death, in patients with sepsis,” said lead author and study presenter Thomas Grünewald, MD, PhD, head of the division of infectious diseases and tropical medicine. “We saw that patients with MPVs higher than 8.7 are much more prone — the odds ratio is 3.2 — to worse outcomes (for example, death) than patients with MPVs lower than 8.7.”
MPV is a machine-calculated measurement of the average size of platelets found in blood and is typically included in blood tests as part of the CBC. Since the average platelet size is larger when the body is producing increased numbers of platelets, the MPV test results can be used to make inferences about platelet production in bone marrow or platelet destruction problems. A typical range of platelet volumes is 9.7–12.8 fL, equivalent to spheres 2.65 to 2.9 µm in diameter.
Related Links:
Klinikum St. Georg
Latest Critical Care News
- Novel Intrabronchial Method Delivers Cell Therapies in Critically Ill Patients on External Lung Support
- Generative AI Technology Detects Heart Disease Earlier Than Conventional Methods
- Wearable Technology Predicts Cardiovascular Risk by Continuously Monitoring Heart Rate Recovery
- Wearable Health Monitoring Device Measures Gases Emitted from and Absorbed by Skin
- Groundbreaking Technology Rapidly Detects Airborne Influenza Viruses
- Handheld Device Could Transform Heart Disease Screening
- Flexible Semi-Autonomous Robot Could Deliver Medicine Inside Body
- Neurorestorative Treatment Strategies Hold Promise for Most Severe Forms of Epilepsy
- Gene Discovery Could Help Grow New Heart Arteries
- Study Discovers Invisible Transmission of Common Hospital-Associated Infection
- Non-Invasive Neuro-Ophthalmology Techniques Could Detect Brain Tumors Earlier
- Mass Manufactured Nanoparticles to Deliver Cancer Drugs Directly to Tumors
- World’s Smallest Pacemaker Fits Inside Syringe Tip
- AI-Powered, Internet-Connected Medical Devices to Revolutionize Healthcare, Finds Study
- Starfish-Inspired Wearable Tech Enables Smarter Heart Monitoring
- AI Eye Scans Could Help Identify Heart Disease and Stroke Risk
Channels
Surgical Techniques
view channel
Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures
Patients diagnosed with coronary artery disease, which is caused by plaque accumulation within the arteries leading to chest pain, shortness of breath, and potential heart attacks, frequently undergo percutaneous... Read more
World's First AI Surgical Guidance Platform Allows Surgeons to Measure Success in Real-Time
Surgeons have always faced challenges in measuring their progress toward surgical goals during procedures. Traditionally, obtaining measurements required stepping out of the sterile environment to perform... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more